Scarica l'app Stockscreener
26.56
4.84%
-1.35
Dopo l'orario di chiusura:
25.57
-0.99
-3.73%
Precedente Chiudi:
$27.91
Aprire:
$28.22
Volume 24 ore:
351.54K
Relative Volume:
1.12
Capitalizzazione di mercato:
$994.69M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+3.95%
1M Prestazione:
+78.26%
6M Prestazione:
+208.48%
1 anno Prestazione:
-8.45%
Intervallo 1D:
$25.63
$28.57
Intervallo di 1 settimana:
$24.31
$29.20
Portata 52W:
$5.485
$31.13
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Nome
Oruka Therapeutics Inc
Settore
Industria
Telefono
650-606-7910
Indirizzo
855 OAK GROVE AVE., MENLO PARK
Confronta ORKA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
26.56 | 1.33B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-10-11 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-17 | Iniziato | Leerink Partners | Outperform |
| 2024-09-16 | Iniziato | TD Cowen | Buy |
| 2024-09-13 | Iniziato | Jefferies | Buy |
| 2018-02-27 | Iniziato | Ascendiant Capital Markets | Buy |
| 2013-10-09 | Iniziato | Dawson James | Buy |
Mostra tutto
Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie
Will Oruka Therapeutics Inc. stock go up soonIPO Watch & Safe Capital Preservation Plans - newser.com
Will Oruka Therapeutics Inc. stock outperform growth indexesMarket Performance Recap & Growth Oriented Trading Recommendations - newser.com
Should you wait for a breakout in Oruka Therapeutics Inc.Market Trend Report & Weekly Top Gainers Trade List - newser.com
Will breakout in Oruka Therapeutics Inc. lead to full recovery2025 Short Interest & Long-Term Growth Portfolio Plans - newser.com
What high frequency data says about Oruka Therapeutics Inc.July 2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Barclays Initiates Oruka Therapeutics at Overweight With $48 Price Target - MarketScreener
Why Oruka Therapeutics Inc. stock attracts global investorsWeekly Trend Recap & Capital Efficient Trade Techniques - newser.com
ORKA: Barclays Initiates Coverage with Overweight Rating | ORKA Stock News - GuruFocus
Is Oruka Therapeutics Inc. stock supported by strong cash flows2025 Investor Takeaways & Safe Entry Momentum Tips - newser.com
Is Oruka Therapeutics’ (ORKA) Fundraising Spree a Sign of Strategic Flexibility or Underlying Caution? - Sahm
Automated trading signals detected on Oruka Therapeutics Inc.Options Play & Safe Capital Investment Plans - newser.com
Oruka Therapeutics (NASDAQ:ORKA) Trading Up 7.5%Should You Buy? - MarketBeat
Oruka Therapeutics (ORKA) Is Up 33.2% After Announcing $1.25B Shelf Registration and $200M Offering - Yahoo Finance
Weiss Ratings Reiterates Sell (D-) Rating for Oruka Therapeutics (NASDAQ:ORKA) - MarketBeat
Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Exploring a Promising 66.83% Potential Upside - DirectorsTalk Interviews
How Oruka Therapeutics Inc. (HQ1) stock reacts to monetary easingBull Run & Weekly Top Gainers Trade List - newser.com
Why retail traders accumulate Oruka Therapeutics Inc. (HQ1) stockMarket Risk Summary & Daily Chart Pattern Signals - newser.com
How Oruka Therapeutics Inc. stock performs in stagflationLong Setup & Consistent Income Trade Ideas - newser.com
Can a trend reversal in Oruka Therapeutics Inc. lead to recoveryWeekly Stock Analysis & Community Consensus Picks - newser.com
What drives Oruka Therapeutics Inc stock priceMarket Entry Points & Budget Investment Success - earlytimes.in
Constellation Brands, Aehr Test Systems And 3 Stocks To Watch Heading Into Monday - Benzinga
How reliable is Oruka Therapeutics Inc. (HQ1) stock dividend growthSwing Trade & Advanced Technical Analysis Signals - newser.com
Oruka Therapeutics Inc Stock Analysis and ForecastValue Stock Picks & Free Real-Time Trading Alerts Every Day - earlytimes.in
Oruka Therapeutics files to sell 39.43M shares of common stock for holders - MSN
Oruka Therapeutics files for mixed shelf of upto $500 millionSEC filing - MarketScreener
Is Oruka Therapeutics Inc. forming a bottoming baseJuly 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
Custom strategy builders for tracking Oruka Therapeutics Inc.2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
What drives Oruka Therapeutics Inc HQ1 stock priceDividend Stability Analysis & Budget Friendly Growth - earlytimes.in
BTIG Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $56 - 富途牛牛
MoonLake Stock Climbs After-Hours: Retail Traders Shrug Off Record Plunge, More Wall Street Downgrades - Stocktwits
Oruka Therapeutics (NASDAQ:ORKA) Shares Gap UpWhat's Next? - MarketBeat
Oruka Therapeutics Inc Azioni (ORKA) Dati Finanziari
Non sono disponibili dati finanziari per Oruka Therapeutics Inc (ORKA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Oruka Therapeutics Inc Azioni (ORKA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Par | 10% Owner |
Feb 13 '25 |
Buy |
11.63 |
14,950 |
173,868 |
4,059,634 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 12 '25 |
Buy |
11.86 |
8,971 |
106,396 |
4,044,684 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 11 '25 |
Buy |
10.95 |
9,593 |
105,043 |
4,035,713 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 10 '25 |
Buy |
10.90 |
574 |
6,257 |
4,026,120 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):